NCT06011460View on ClinicalTrials.gov

Observation of Clozapine Treatment Safety in Bipolar Disorder.

Enrolling by invitationOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2027

Conditions
Bipolar Disorder
Interventions
DRUG

Clozapine

"Diagnosis of treatment-resistant depressive episode in the course of bipolar disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM-5).~Age from 18 to 65 years old."

Trial Locations (1)

80-214

Department of Psychiatry, Medical University of Gdańsk, Gdansk

All Listed Sponsors
lead

Medical University of Gdansk

OTHER